Suzanne E Mitchell1,2,3, Matthew Reichert2,4, Jessica Martin Howard5, Katherine Krizman5, Alexa Bragg5, Molly Huffaker2, Kimberly Parker5, Mary Cawley5, Hannah Webb Roberts2, Yena Sung2, Jennifer Brown6, Larry Culpepper5, Howard J Cabral7, Brian W Jack5,2. 1. Department of Family Medicine, Boston University School of Medicine, Boston, Massachusetts Suzanne.Mitchell@bmc.org. 2. Department of Family Medicine, Boston Medical Center, Boston, Massachusetts. 3. Department of Family Medicine, University of Massachusetts Medical School, Worcester, Massachusetts. 4. Department of Government, Harvard University, Cambridge, Massachusetts. 5. Department of Family Medicine, Boston University School of Medicine, Boston, Massachusetts. 6. Department of Psychiatry, Mount Auburn Hospital, Cambridge, Massachusetts. 7. Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts.
Abstract
PURPOSE: To determine if hospitalized patients with depressive symptoms will benefit from post-discharge depression treatment with care transition support. METHODS: This is a randomized controlled trial of hospitalized patients with patient health questionnaire-9 score of 10 or more. We delivered the Re-Engineered Discharge (RED) and randomized participants to groups receiving RED-only or RED for Depression (RED-D), a 12-week post-discharge telehealth intervention including cognitive behavioral therapy, self-management support, and patient navigation. Primary outcomes were hospital readmission and reutilization rates at 30 and 90 days post discharge. RESULTS: We randomized 709 participants (353 RED-D, 356 RED-only). At 90 days, 265 (75%) intervention participants had received at least 1 RED-D session (median 4). At 30 days, the intention-to-treat analysis showed no differences between RED-D vs RED-only in hospital readmission (9% vs 10%, incidence rate ratio [IRR] 0.92 [95% CI, 0.56-1.52]) or reutilization (27% vs 24%, IRR 1.14 [95% CI, 0.85-1.54]). The intention-to-treat analysis also showed no differences at 90 days in readmission (28% vs 21%, IRR 1.30 [95% CI, 0.95-1.78]) or reutilization (70% vs 57%, IRR 1.22 [95% CI, 1.01-1.49]). In the as-treated analysis, each additional RED-D session was associated with a decrease in 30- and 90-day readmissions. At 30 days, among 104 participants receiving 3 or more sessions, there were fewer readmissions (3% vs 10%, IRR 0.30 [95% CI, 0.07-0.84]) compared with the control group. At 90 days, among 109 participants receiving 6 or more sessions, there were fewer readmissions (11% vs 21%, IRR 0.52 [95% CI, 0.27-0.92]). Intention-to-treat analysis showed no differences between study groups on secondary outcomes. CONCLUSIONS: Care transition support and post-discharge depression treatment can reduce unplanned hospital use with sufficient uptake of the RED-D intervention.
PURPOSE: To determine if hospitalized patients with depressive symptoms will benefit from post-discharge depression treatment with care transition support. METHODS: This is a randomized controlled trial of hospitalized patients with patient health questionnaire-9 score of 10 or more. We delivered the Re-Engineered Discharge (RED) and randomized participants to groups receiving RED-only or RED for Depression (RED-D), a 12-week post-discharge telehealth intervention including cognitive behavioral therapy, self-management support, and patient navigation. Primary outcomes were hospital readmission and reutilization rates at 30 and 90 days post discharge. RESULTS: We randomized 709 participants (353 RED-D, 356 RED-only). At 90 days, 265 (75%) intervention participants had received at least 1 RED-D session (median 4). At 30 days, the intention-to-treat analysis showed no differences between RED-D vs RED-only in hospital readmission (9% vs 10%, incidence rate ratio [IRR] 0.92 [95% CI, 0.56-1.52]) or reutilization (27% vs 24%, IRR 1.14 [95% CI, 0.85-1.54]). The intention-to-treat analysis also showed no differences at 90 days in readmission (28% vs 21%, IRR 1.30 [95% CI, 0.95-1.78]) or reutilization (70% vs 57%, IRR 1.22 [95% CI, 1.01-1.49]). In the as-treated analysis, each additional RED-D session was associated with a decrease in 30- and 90-day readmissions. At 30 days, among 104 participants receiving 3 or more sessions, there were fewer readmissions (3% vs 10%, IRR 0.30 [95% CI, 0.07-0.84]) compared with the control group. At 90 days, among 109 participants receiving 6 or more sessions, there were fewer readmissions (11% vs 21%, IRR 0.52 [95% CI, 0.27-0.92]). Intention-to-treat analysis showed no differences between study groups on secondary outcomes. CONCLUSIONS: Care transition support and post-discharge depression treatment can reduce unplanned hospital use with sufficient uptake of the RED-D intervention.
Authors: Rebecca L Reese; Kenneth E Freedland; Brian C Steinmeyer; Michael W Rich; Justin W Rackley; Robert M Carney Journal: Circ Cardiovasc Qual Outcomes Date: 2011-10-18
Authors: Ramon S Cancino; Larry Culpepper; Ekaterina Sadikova; Jessica Martin; Brian W Jack; Suzanne E Mitchell Journal: J Hosp Med Date: 2014-03-06 Impact factor: 2.960
Authors: W Jiang; J Alexander; E Christopher; M Kuchibhatla; L H Gaulden; M S Cuffe; M A Blazing; C Davenport; R M Califf; R R Krishnan; C M O'Connor Journal: Arch Intern Med Date: 2001 Aug 13-27
Authors: Richard B Balaban; Alison A Galbraith; Marguerite E Burns; Catherine E Vialle-Valentin; Marc R Larochelle; Dennis Ross-Degnan Journal: J Gen Intern Med Date: 2015-01-24 Impact factor: 5.128
Authors: Jenelle L Pederson; Sumit R Majumdar; Mary Forhan; Jeffrey A Johnson; Finlay A McAlister Journal: Gen Hosp Psychiatry Date: 2015-12-18 Impact factor: 3.238
Authors: Jason Roberge; Andrew McWilliams; Jing Zhao; William E Anderson; Timothy Hetherington; Christine Zazzaro; Elisabeth Hardin; Amy Barrett; Manuel Castro; Margaret E Balfour; James Rachal; Constance Krull; Wayne Sparks Journal: JAMA Netw Open Date: 2020-01-03